Anne S. de Groot
Amministratore Delegato presso EpiVax, Inc.
Posizioni attive di Anne S. de Groot
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
EpiVax, Inc.
 EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Amministratore Delegato | 01/01/1998 | - |
| Direttore Tecnico/Scientifico/R&S | 01/01/1998 | - | |
| Fondatore | 07/12/2009 | - | |
| Brown University | Corporate Officer/Principal | - | - |
| University of Rhode Island | Corporate Officer/Principal | - | - |
| GAIA Vaccine Foundation | Direttore Tecnico/Scientifico/R&S | 01/01/2002 | - |
| Fondatore | 01/01/2002 | - | |
Epivax Oncology, Inc.
 Epivax Oncology, Inc. BiotechnologyHealth Technology Epivax Oncology, Inc. engages in computational-immunology, genomics and vaccine design. It develops mutanome-directed, neo-epitope personalized therapeutic vaccines. The company was founded by Gad Berdugo, Anne De Groot, and Martin William in 2017 and is headquartered in New York, NY. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | - | - | |
| Direttore Tecnico/Scientifico/R&S | - | - | |
| Presidente | - | - |
Storia della carriera di Anne S. de Groot
Formazione di Anne S. de Groot
| Smith College | Undergraduate Degree |
| The University of Chicago | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
Posizioni
| Chief Tech/Sci/R&D Officer | 3 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Settori
| Consumer Services | 5 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
EpiVax, Inc.
EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Health Technology |
| GAIA Vaccine Foundation | |
Epivax Oncology, Inc.
Epivax Oncology, Inc. BiotechnologyHealth Technology Epivax Oncology, Inc. engages in computational-immunology, genomics and vaccine design. It develops mutanome-directed, neo-epitope personalized therapeutic vaccines. The company was founded by Gad Berdugo, Anne De Groot, and Martin William in 2017 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Anne S. de Groot
- Esperienza
